Post Tagged with: "NASDAQ:ARNA"

Active Stocks: Oracle Corporation (NYSE:ORCL), Zynga Inc (NASDAQ:ZNGA), Arena Pharmaceuticals (NASDAQ:ARNA), Baidu Inc (ADR) (NASDAQ:BIDU), Express Scripts Holding Company (NASDAQ:ESRX)

March 18, 2015 at 1:07 pm 0 comments

On Tuesday shares of Oracle Corporation (NYSE:ORCL) closed at $42.87. Company’s sales growth for last 5 years was 10.50% and EPS growth for next 5 years is recorded as 8.37%. Oracle Corporation (NYSE:ORCL) reported in-line earnings for the fiscal thirdRead More

Eye Catching Stocks: MGIC Investment Corp. (NYSE:MTG), Google Inc (NASDAQ:GOOGL), REEDS (NYSEMKT:REED), Zynga Inc (NASDAQ:ZNGA), Arena Pharmaceuticals (NASDAQ:ARNA)

March 17, 2015 at 11:06 am 0 comments

MGIC Investment Corporation (NYSE:MTG) on 9 March 2015, issued an Operational Summary of its insurance subsidiaries for the month of February 2015 for their primary mortgage insurance. Primary new insurance was $2.5 billion. On Monday shares of MGIC Investment Corp.Read More

Stocks Getting Hot: Cytosorbents Corporation (NASDAQ:CTSO), Amarin Corporation plc (NASDAQ:AMRN), Tesla Motors Inc (NASDAQ:TSLA), Arena Pharmaceuticals (NASDAQ:ARNA), SanDisk Corp. (NASDAQ:SNDK)

March 16, 2015 at 2:17 pm 0 comments

It was reported on 11 March 2015, that CytoSorbents Corporation (NASDAQ:CTSO) commercializing its CytoSorb extracorporeal cytokine adsorber to treat critically-ill and cardiac surgery patients in multiple countries worldwide, announced the international launch of its new CytoSorb Therapy product website. OnRead More

Stocks in news: Numerex Corp. (NASDAQ:NMRX), StemCells Inc. (NASDAQ:STEM), Arena Pharmaceuticals (NASDAQ:ARNA), Identiv (NASDAQ:INVE), Vantage Drilling Company (NYSEMKT:VTG)

March 13, 2015 at 1:28 pm 0 comments

Numerex Corp (Nasdaq:NMRX), announced financial results for its fourth quarter and full year ended December 31, 2014. Sales and marketing expenses were $2.8 million compared to $2.6 million. The increase was due to our acquisition of Omnilink and the additionRead More

Market Alert: Arena Pharmaceuticals (NASDAQ:ARNA), North Atlantic Drilling Limited (NYSE:NADL), Peabody Energy Corp. (NYSE:BTU), Bristol-Myers Squibb Company (NYSE:BMY), The Boeing (NYSE:BA)

March 12, 2015 at 1:46 pm 0 comments

On March 2, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2014. Revenues totaled $9.2 million, including $3.8 million in net product sales of BELVIQ, ofRead More

Market Watch List: IGI, Laboratories (NYSEMKT:IG), MGM Resorts International (NYSE:MGM), Zynga Inc (NASDAQ:ZNGA), CTC Media, Inc (NASDAQ:CTCM), Arena Pharmaceuticals (NASDAQ:ARNA)

March 12, 2015 at 12:32 pm 0 comments

IGI, Laboratories, Inc. (NYSEMKT:IG) on March 02, 2015, reported its financial results for the fourth quarter and year ended December 31, 2014. Fourth quarter highlights included: Total revenues of $13.7 million in the fourth quarter of 2014, an increase ofRead More

Morning Movers: Arena Pharmaceuticals (NASDAQ:ARNA), ArQule Inc. (NASDAQ:ARQL), Intellicheck Mobilisa (NYSEMKT:IDN), Analogic Corporation (NASDAQ:ALOG), Western Refining Logistics, LP (NYSE:WNRL)

March 11, 2015 at 2:24 pm 0 comments

Arena Pharmaceuticals (NASDAQ:ARNA) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a research report issued to clients and investors on Friday. They currently have a $4.00 price target on the stock. Zacks‘s price target wouldRead More

5 Active Stocks: Arena Pharmaceuticals (NASDAQ:ARNA), Calumet Specialty Products Partners LP (NASDAQ:CLMT), Quest Diagnostics Inc. (NYSE:DGX), Rock-Tenn (NYSE:RKT), GTT Communications (NYSE:GTT)

March 11, 2015 at 12:12 pm 0 comments

On March 02, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported a fourth-quarter 2014 loss of 15 cents per share, wider than the Zacks Consensus Estimate of a loss of 13 cents and the year-ago loss of 11 cents.Total revenues increased 41.1% yearRead More

Stocks Buzz: Arena Pharmaceuticals (NASDAQ:ARNA), Baidu Inc (ADR) (NASDAQ:BIDU), DexCom (NASDAQ:DXCM), Canadian Solar Inc. (NASDAQ:CSIQ), Boston Scientific Corporation (NYSE:BSX)

March 11, 2015 at 12:04 pm 0 comments

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) on March 02, 2015, announced financial results for the fourth quarter and full year ended December 31, 2014. Fourth quarter highlights included: Revenues totaled $9.2 million, including $3.8 million in net product sales of BELVIQ, ofRead More

Investor’s pick: Arena Pharmaceuticals (NASDAQ:ARNA), Ford Motor Company (NYSE:F), Harvard Bioscience Inc. (NASDAQ:HBIO), International Business Machines Corporation (NYSE:IBM), MOCON Inc. (NASDAQ:MOCO)

March 11, 2015 at 11:57 am 0 comments

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) on March 02, 2015, announced financial results for the fourth quarter and full year ended December 31, 2014. Fourth quarter highlights included: Revenues totaled $9.2 million, including $3.8 million in net product sales of BELVIQ, ofRead More